Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Fulvestrant × Dermatologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 28 Tumor-Agnostic 3 Thoracic 3 Gynecologic 3 Gastrointestinal 2 Endocrine 2 Other solid neoplasm 1 Lymphoid 1 Dermatologic 1

Conditions

Melanoma 2 Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

pembrolizumab 28 Nivolumab 21 Cyclophosphamide 20 Ipilimumab 19 aldesleukin 17 Interleukin-2 13 fludarabine 12 Specimen Handling 11 fludarabine phosphate 9 Radiosurgery 9 Magnetic Resonance Spectroscopy 9 Dacarbazine 9 Biopsy 9 Temozolomide 6 dabrafenib 5 cemiplimab 5 trametinib 4 sargramostim 4 binimetinib 4 avelumab 4 Vemurafenib 4 Radiotherapy 4 Cisplatin 4 Bevacizumab 4 lenvatinib 3 encorafenib 3 durvalumab 3 Pemetrexed 3 Paclitaxel 3 Lenalidomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07340619 2026-01-14

EPIBREAST

UNICANCER

Phase 2 Not yet recruiting

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡